Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
NPJ Precision Oncology
|
March 2, 2022
ESCCAL-1 promotes cell-cycle progression by interacting with and stabilizing galectin-1 in esophageal squamous cell carcinoma
Yuanbo Cui, Ming Yan, Wei Wu, et al.
Annals of Medicine
|
October 9, 2025
Propofol in combination with salvianolic acid A protect against lipopolysaccharide-induced cardiac dysfunction and ferroptosis through activating the SIRT1/FoxO1 signaling under diabetic condition
Ronghui Han, Kaijia Han, Jianyu Zhu, et al.
Molecular Genetics and Metabolism
|
November 5, 2017
Tandem mass spectrometry assay of β-glucocerebrosidase activity in dried blood spots eliminates false positives detected in fluorescence assay
Pavlina Wolf, Roy N Alcalay, Christopher Liong, et al.
Plos One
|
May 31, 2014
Identification of druggable cancer driver genes amplified across TCGA datasets
Ying Chen, Jeremy McGee, Xianming Chen, et al.
Journal of Alzheimer'S Disease Reports
|
October 6, 2025
A surgical therapy for Alzheimer's disease with lymphaticovenular anastomosis
Xiwen Ma, Feiyun Wang, Guiqing Wang, et al.
Future Oncology (London, England)
|
April 15, 2021
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma
Mrinal Gounder, Albiruni R Abdul Razak, Adrienne M Gilligan, et al.
Cancer Research
|
September 6, 2014
Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers
Vidhya G Krishnan, Philip J Ebert, Jason C Ting, et al.
Cancer Cell
|
September 8, 2015
Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers
Sheng-Bin Peng, James R Henry, Michael D Kaufman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 26, 2022
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study
Michael Schuster, Josée Zijlstra, Rene-Olivier Casasnovas, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 8, 2021
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes
Rene-Olivier Casasnovas, George Follows, Josee M Zijlstra, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
NPJ Precision Oncology
|
March 2, 2022
ESCCAL-1 promotes cell-cycle progression by interacting with and stabilizing galectin-1 in esophageal squamous cell carcinoma
Yuanbo Cui, Ming Yan, Wei Wu, et al.
Annals of Medicine
|
October 9, 2025
Propofol in combination with salvianolic acid A protect against lipopolysaccharide-induced cardiac dysfunction and ferroptosis through activating the SIRT1/FoxO1 signaling under diabetic condition
Ronghui Han, Kaijia Han, Jianyu Zhu, et al.
Molecular Genetics and Metabolism
|
November 5, 2017
Tandem mass spectrometry assay of β-glucocerebrosidase activity in dried blood spots eliminates false positives detected in fluorescence assay
Pavlina Wolf, Roy N Alcalay, Christopher Liong, et al.
Plos One
|
May 31, 2014
Identification of druggable cancer driver genes amplified across TCGA datasets
Ying Chen, Jeremy McGee, Xianming Chen, et al.
Journal of Alzheimer'S Disease Reports
|
October 6, 2025
A surgical therapy for Alzheimer's disease with lymphaticovenular anastomosis
Xiwen Ma, Feiyun Wang, Guiqing Wang, et al.
Future Oncology (London, England)
|
April 15, 2021
Health-related quality of life and pain with selinexor in patients with advanced dedifferentiated liposarcoma
Mrinal Gounder, Albiruni R Abdul Razak, Adrienne M Gilligan, et al.
Cancer Research
|
September 6, 2014
Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers
Vidhya G Krishnan, Philip J Ebert, Jason C Ting, et al.
Cancer Cell
|
September 8, 2015
Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers
Sheng-Bin Peng, James R Henry, Michael D Kaufman, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
January 26, 2022
Effect of Prior Therapy and Disease Refractoriness on the Efficacy and Safety of Oral Selinexor in Patients with Diffuse Large B-cell Lymphoma (DLBCL): A Post-hoc Analysis of the SADAL Study
Michael Schuster, Josée Zijlstra, Rene-Olivier Casasnovas, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
September 8, 2021
Comparison of the Effectiveness and Safety of the Oral Selective Inhibitor of Nuclear Export, Selinexor, in Diffuse Large B Cell Lymphoma Subtypes
Rene-Olivier Casasnovas, George Follows, Josee M Zijlstra, et al.
Page
of 3